19 June 2013
Keywords: Boehringer Ingelheim, Viramune, Flomax, Impax, Patents, USA
Article | 07 October 2009
Independent German drugmaker Boehringer Ingelheim’s US subsidiary has launched the Viramune (nevirapine) tablets/oral suspension Co-Pay Savings Program, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.